Introduction The Models of Patient Engagement for Alzheimer's Disease (MOPEAD) project was conceived to explore innovative complementary strategies to uncover hidden prodromal and mild Alzheimer's disease (AD) dementia cases and to raise awareness both in the general public and among health professionals about the importance of early diagnosis. Methods Four different strategies or RUNs were used: (a) a web-based (WB) prescreening tool, (2) an open house initiative (OHI), (3) a primary care-based protocol for early detection of cognitive decline (PC), and (4) a tertiary care-based pre-screening at diabetologist clinics (DC). Results A total of 1129 patients at high risk of having prodromal AD or dementia were identified of 2847 pre-screened ...
Alzheimer’s disease (AD) is a major cause of the rapidly growing and crushing aging challenge that t...
Alzheimer’s disease is a neurodegenerative disease that affects more than 55 million Americans. By t...
Due to the aging population, within the next 20-30years the number of individuals with dementia, mos...
Introduction The Models of Patient Engagement for Alzheimer's Disease (MOPEAD) project was conceived...
Introduction: The Models of Patient Engagement for Alzheimer's Disease (MOPEAD) project was conceive...
Introduction Innovative patient engagement models are required to identify people with prodromal and...
In most, if not all health systems, dementia is underdiagnosed, and when diagnosis occurs, it is typ...
In most, if not all health systems, dementia is underdiagnosed, and when diagnosis occurs, it is typ...
Background: For care planning and support, under-detection and late diagnosis of Alzheimer's disease...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is the most common cause o...
Item does not contain fulltextBACKGROUND: There is an urgent need to identify subjects with Alzheime...
Background: There is an urgent need to identify subjects with Alzheimer's disease (AD) in the predem...
Alzheimer’s disease (AD) is a major cause of the rapidly growing and crushing aging challenge that t...
Alzheimer’s disease is a neurodegenerative disease that affects more than 55 million Americans. By t...
Due to the aging population, within the next 20-30years the number of individuals with dementia, mos...
Introduction The Models of Patient Engagement for Alzheimer's Disease (MOPEAD) project was conceived...
Introduction: The Models of Patient Engagement for Alzheimer's Disease (MOPEAD) project was conceive...
Introduction Innovative patient engagement models are required to identify people with prodromal and...
In most, if not all health systems, dementia is underdiagnosed, and when diagnosis occurs, it is typ...
In most, if not all health systems, dementia is underdiagnosed, and when diagnosis occurs, it is typ...
Background: For care planning and support, under-detection and late diagnosis of Alzheimer's disease...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is the most common cause o...
Item does not contain fulltextBACKGROUND: There is an urgent need to identify subjects with Alzheime...
Background: There is an urgent need to identify subjects with Alzheimer's disease (AD) in the predem...
Alzheimer’s disease (AD) is a major cause of the rapidly growing and crushing aging challenge that t...
Alzheimer’s disease is a neurodegenerative disease that affects more than 55 million Americans. By t...
Due to the aging population, within the next 20-30years the number of individuals with dementia, mos...